I was hoping they could punch out a phase 2 TBI trial but by the sounds of it they are back to square one with this glaucoma collaboration. Not much to get excited about besides the cash reserves. Surprised that major shareholders are still hanging around as well. I thought Tattarang would have tried to get some of their money back and sell the IP to the highest bidder.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 43691 | 8.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.6¢ | 34737 | 1 |
View Market Depth
| Last trade - 13.28pm 21/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable